About Codiak BioSciences
About Codiak BioSciences
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
|
|
|
1-10 employees
View all Codiak BioSciences employees
|
|
Biotechnology
|
|
35 CambridgePark Dr, Cambridge, Massachusetts 02140, US
|
|
2015
|
Codiak BioSciences Alternatives
Frequently Asked Questions about Codiak BioSciences
Douglas Williams is the CEO of Codiak BioSciences. To contact Douglas Williams email at [email protected].
Codiak BioSciences Staff Directory
Search Codiak BioSciences Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
